CTSO
Cytosorbents Corp
Price:  
0.79 
USD
Volume:  
157,768.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CTSO WACC - Weighted Average Cost of Capital

The WACC of Cytosorbents Corp (CTSO) is 7.7%.

The Cost of Equity of Cytosorbents Corp (CTSO) is 7.75%.
The Cost of Debt of Cytosorbents Corp (CTSO) is 7.00%.

Range Selected
Cost of equity 5.70% - 9.80% 7.75%
Tax rate 3.10% - 4.10% 3.60%
Cost of debt 7.00% - 7.00% 7.00%
WACC 5.8% - 9.5% 7.7%
WACC

CTSO WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.39 0.89
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.70% 9.80%
Tax rate 3.10% 4.10%
Debt/Equity ratio 0.11 0.11
Cost of debt 7.00% 7.00%
After-tax WACC 5.8% 9.5%
Selected WACC 7.7%